STROEER SE + CO KGAA/ DE0007493991 /
2024-05-13 9:05:09 AM | Chg. +0.25 | Volume | Bid2:33:57 PM | Ask2:33:57 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
63.55EUR | +0.39% | 0 Turnover: - |
62.50Bid Size: 326 | 63.70Ask Size: 146 | 3.52 bill.EUR | 2.92% | 37.87 |
Newsfile Corp
3:03 PM
One of 2024's Must Read Memoirs About the Life of a Mother, Wife, and Caregiver Is 'Notes from a Bla...
GlobeNewswire
2:50 PM
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2:50 PM
Outlook Therapeutics® Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5...
GlobeNewswire
2:48 PM
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Squarespace, I...
GlobeNewswire
2:36 PM
DEADLINE TOMORROW: Berger Montague Advises Innoviz Technologies Ltd. (NASDAQ: INVZ) Investors to Inq...
GlobeNewswire
2:35 PM
DeFi Technologies Inc. Featured in Syndicated Broadcast Covering Subsidiary’s AUM of C$748M, a 47.2%...
GlobeNewswire
2:33 PM
Stanley Martin Holdings Acquires Prestige Corporate Development and Prestige Site Works
GlobeNewswire
2:30 PM
Backblaze to Present at the 19th Annual Needham Technology, Media, & Consumer Conference
GlobeNewswire
2:30 PM
Madison Realty Capital and Unity Capital Originate $100 Million Construction Loan for Mixed-Use Mult...
GlobeNewswire
2:30 PM
Checkpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Confere...
GlobeNewswire
2:30 PM
Bitdeer Reports Unaudited Financial Results for the First Quarter of 2024 and Operational Update